tirzepatide original Injection | Starts at $249/mo Tirzepatide | DirectMeds

BCBS Michigan cites concerns about safety, effectiveness, and cost for this decision

Unrealised Expectations Despite progress, several anticipated 2025 milestones did not come to fruition: Regulatory progress stalled: FDAs obesity drug guidance, published in draft form in January 2025, remains unfinalised, whilst EMA has yet to update its 2016 guideline

Here, emulating a clinical trial, the authors show that GLP1-RA use in patients with CKD is associated with lower rate of acute healthcare utilization, all-cause death and kidney events compared to DPP4i.

Discover how this GLP-1 medication works, what real users report, and why PlexusDx offers accessible compounded semaglutide therapy across all 50 states

Get a clear chart and learn what matters for safe use.

GLP-1 agonists are shockingly expensive given that they are not a great breakthrough